English, Article edition: Economic Evaluations of Influenza Vaccination in the Elderly: Impact on Public Health Policy Susan C. Wood; Van Hung Nguyen; Claudia Schmidt

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/92446
Physical Description
  • article
Language
  • English

Edition details

Title
  • Economic Evaluations of Influenza Vaccination in the Elderly: Impact on Public Health Policy
Author
  • Susan C. Wood
  • Van Hung Nguyen
  • Claudia Schmidt
Physical Description
  • article
Notes
  • Objective: To determine 1. whether influenza vaccination in the elderly is cost effective or cost saving compared with a non-intervention strategy and 2. whether it is worth framing a vaccination policy for this population. Background: Influenza causes substantial morbidity and mortality in elderly people. Despite the availability of effective vaccines against this disease, vaccine coverage in the elderly is low in many countries. Evaluations of the economic impact of influenza vaccination can support public health policy decisions concerning vaccination and also may help influence changes in practice behaviour. Methods: We performed a literature review of cost-benefit and cost-effectiveness evaluations of influenza vaccination in the elderly. We provide a summary of the principal findings from 11 economic evaluations of influenza immunisation and discuss their effect on policy decisions for vaccination in the elderly population. Results: The cost-benefit and cost-effectiveness results in elderly individuals, derived from 7 model-based simulations, 3 observational analyses and a case-control study, all support the recommendations for vaccination of all persons of 65 years and over that are currently endorsed in the US, Australia, New Zealand and many European countries. All evaluations showed that influenza immunisation was cost effective or would result in cost savings compared with a no-vaccination strategy. Conclusions: Although clinical and economic data indicate the benefit of influenza vaccination in the elderly, the vaccine coverage rate in many countries is disappointing, even when vaccine is provided free of charge. It is clear that strategies aimed at the patient or healthcare provider are needed to increase implementation of a vaccination policy to ensure that any recommended vaccine programme is clinically and economically effective.
  • Cost effectiveness, Elderly, Influenza virus infections, Influenza virus vaccine, Pharmacoeconomics
  • RePEc:wkh:dmhout:v:8:y:2000:i:5:p:273-285
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment